Chi SG - Search Results

1

Targeted delivery of anti-miRNA21 sensitizes PD-L1^high tumor to immunotherapy by promoting immunogenic cell death.

Kim EH, Choi J, Jang H, Kim Y, Lee JW, Ryu Y, Choi J, Choi Y, Chi SG, Kwon IC, Yang Y, Kim SH. Kim EH, et al. Among authors: chi sg. Theranostics. 2024 Jun 17;14(10):3777-3792. doi: 10.7150/thno.97755. eCollection 2024. Theranostics. 2024. PMID: 38994018 Free PMC article.

2

Design of PD-L1-Targeted Lipid Nanoparticles to Turn on PTEN for Efficient Cancer Therapy.

Kim Y, Choi J, Kim EH, Park W, Jang H, Jang Y, Chi SG, Kweon DH, Lee K, Kim SH, Yang Y. Kim Y, et al. Among authors: chi sg. Adv Sci (Weinh). 2024 Jun;11(22):e2309917. doi: 10.1002/advs.202309917. Epub 2024 Mar 23. Adv Sci (Weinh). 2024. PMID: 38520717 Free PMC article.

3

Targeting miR-21 to Overcome P-glycoprotein Drug Efflux in Doxorubicin-Resistant 4T1 Breast Cancer.

Kim EH, Ryu Y, Choi J, Park D, Lee JW, Chi SG, Kim SH, Yang Y. Kim EH, et al. Among authors: chi sg. Biomater Res. 2024 Oct 21;28:0095. doi: 10.34133/bmr.0095. eCollection 2024. Biomater Res. 2024. PMID: 39434899 Free PMC article.

4

Polyamine and EIF5A hypusination downstream of c-Myc confers targeted therapy resistance in BRAF mutant melanoma.

Park BS, Jeon H, Kim Y, Kwon H, Choi GE, Chi SG, Park HM, Lee H, Kim T. Park BS, et al. Among authors: chi sg. Mol Cancer. 2024 Jul 4;23(1):136. doi: 10.1186/s12943-024-02031-w. Mol Cancer. 2024. PMID: 38965534 Free PMC article.

5

Efficient prioritization of CRISPR screen hits by accounting for targeting efficiency of guide RNA.

Park BS, Jeon H, Chi SG, Kim T. Park BS, et al. Among authors: chi sg. BMC Biol. 2023 Feb 24;21(1):45. doi: 10.1186/s12915-023-01536-y. BMC Biol. 2023. PMID: 36829149 Free PMC article.

6

XAF1 antagonizes TRIM28 activity through the assembly of a ZNF313-mediated destruction complex to suppress tumor malignancy.

Jang SH, Choi HW, Ahn J, Jang S, Yoon JH, Lee MG, Chi SG. Jang SH, et al. Among authors: chi sg. Mol Biomed. 2024 Nov 13;5(1):58. doi: 10.1186/s43556-024-00224-9. Mol Biomed. 2024. PMID: 39532800 Free PMC article.

7

Richter transformation acquiring PLCG2 mutation during Bruton tyrosine kinase inhibitors treatment.

Tsushima T, Sato N, Guo YM, Nakamura H, Kunisada K, Chi SG, Akie K, Takahashi Y, Nakamura S, Shimada K, Ishii G, Minami Y, Yuda J. Tsushima T, et al. Among authors: chi sg. EJHaem. 2024 Apr 14;5(3):642-645. doi: 10.1002/jha2.891. eCollection 2024 Jun. EJHaem. 2024. PMID: 38895067 Free PMC article. No abstract available.

8

Implications for Combination Therapy of Selective Monoamine Reuptake Inhibitors on Dopamine Transporters.

Ahn H, Park K, Kim D, Chi SG, Choi KH, Han SJ, Song C. Ahn H, et al. Among authors: chi sg. Biomedicines. 2023 Oct 20;11(10):2846. doi: 10.3390/biomedicines11102846. Biomedicines. 2023. PMID: 37893219 Free PMC article.

9

Discovery of dioxo-benzo[b]thiophene derivatives as potent YAP-TEAD interaction inhibitors for treating breast cancer.

Son Y, Kim J, Kim Y, Chi SG, Kim T, Yu J. Son Y, et al. Among authors: chi sg. Bioorg Chem. 2023 Feb;131:106274. doi: 10.1016/j.bioorg.2022.106274. Epub 2022 Nov 16. Bioorg Chem. 2023. PMID: 36434952

10

Covalent organic framework nanomedicines: Biocompatibility for advanced nanocarriers and cancer theranostics applications.

Singh N, Kim J, Kim J, Lee K, Zunbul Z, Lee I, Kim E, Chi SG, Kim JS. Singh N, et al. Among authors: chi sg. Bioact Mater. 2022 Sep 14;21:358-380. doi: 10.1016/j.bioactmat.2022.08.016. eCollection 2023 Mar. Bioact Mater. 2022. PMID: 36185736 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters